White label ELPA - ClinicalTrials.eu

Study of Lutetium (177Lu) Oxodotreotide, Carboplatin, Etoposide, and Atezolizumab in Newly Diagnosed Extensive Stage Small Cell Lung Cancer Patients

Not recruiting

1 1 1 1
Investigated diseases:
- Small cell lung cancer extensive stage
Investigated drugs:
+2
Tulisokibart in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease

Not recruiting

2 1
Investigated drugs:
- Tulisokibart
+2
Pharmacokinetics of Intravenous Lidocaine Hydrochloride in Young and Elderly Patients Undergoing Anesthesia

Not recruiting

3 1 1 1
Investigated drugs:
- Lidocaine Hydrochloride
Faricimab for Choroidal Neovascularization Secondary to Pathologic Myopia in Patients with Pathologic Myopia

Not recruiting

3 1 1 1
Investigated diseases:
- Choroidal neovascularisation
Investigated drugs:
- Faricimab
- Ranibizumab
Phase III Study Comparing FOLFOX Plus Panitumumab Followed by FOLFIRI Plus Bevacizumab Versus FOLFOX Plus Bevacizumab Followed by FOLFIRI Plus Panitumumab in Wild-Type RAS Metastatic Colorectal Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Colorectal cancer metastatic
Investigated drugs:
Study of Cabozantinib and Atezolizumab Compared to Hormonal Therapy in Adults with Metastatic Castration-Resistant Prostate Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Hormone-refractory prostate cancer
Investigated drugs:
+3
Study of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Investigated drugs:
+7
A study to evaluate the effectiveness and safety of tulisokibart and placebo in patients with moderate to severe ulcerative colitis

Not recruiting

3 1
Investigated drugs:
- Tulisokibart
+15
A study to evaluate the safety and effectiveness of BO-112 injections in patients with resectable primary basal cell carcinoma.

Not recruiting

2 1 1
Investigated diseases:
- Basal cell carcinoma
Investigated drugs:
- Polyinosinic:polycytidylic Acid
Efficacy and Safety Evaluation of Litifilimab in Adults with Active Systemic Lupus Erythematosus on Nonbiologic Standard of Care: A Phase 3 Randomized Controlled Trial

Not recruiting

3 1
Investigated diseases:
- Systemic lupus erythematosus
Investigated drugs:
- Litifilimab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies